NCT04638881View on ClinicalTrials.gov

Magnesium for Peroral Endoscopic Myotomy

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

December 28, 2020

Primary Completion Date

April 13, 2023

Study Completion Date

April 13, 2023

Conditions
Esophageal Spasm
Interventions
DRUG

Magnesium sulfate

Magnesium infusion 50 mg/kg bolus over 15 minutes and 25 mg/kg/hr infusion, both administered intraoperatively under general anesthesia.

DRUG

Normal Saline

Placebo. Bolus and infusion administered similarly under general anesthesia.

Trial Locations (1)

94305

Stanford Health Care, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT04638881 - Magnesium for Peroral Endoscopic Myotomy | Biotech Hunter | Biotech Hunter